Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.
Aetna Once Offered To Buy NY Startup ZocDoc For More Than $300 Million And The Founders Walked Away
Aetna Once Offered To Buy NY Startup ZocDoc For More Than $300 Million And The Founders Walked Away
Alyson ShontellSep 6, 2013, 00:36 IST
Insurance company Aetna once offered to buy ZocDoc for more than $300 million but ZocDoc's founders walked away, multiple sources tell Business Insider.ZocDoc was founded in 2007 and has raised nearly $100 million plus a $55 million convertible note. It is an app and website that helps people schedule in-network doctor appointments right when they're needed. That means no scheduling months in advance or waiting on hold; practices pay $300 per month to be listed on ZocDoc. In September 2011, investors gave ZocDoc $75 million at a $700 million valuation. ZocDoc's founders, Cyrus Massoumi, Nick Ganju and Oliver Kharraz, are focused on creating a valuable public company, so a source says there was little-to-no interest in Aetna's offer.Shortly after ZocDoc rejected Aetna, the insurance giant announced the acquisition of a ZocDoc competitor, Healthagen in December 2011. Healthagen made a similar appointment app called iTriage. It's easy to see why Aetna would want to own ZocDoc. Larger companies are realizing the importance of lead-generation networks like ZocDoc. Proctor and Gamble acquired a network of doctors, MDVIP, for example.
Walking away from a nine-figure offer couldn't have been easy, but ZocDoc's value has only increased since then. ZocDoc is now profitable in almost all of its 35 markets. Mobile bookings are up 500% year over year, and website bookings are up 200%.
ZocDoc declined to comment for this story. Aetna has not returned a request for comment.
